The next frontier in prenatal screening isn't chromosomes - it's single genes. As sequencing costs drop and analytical methods improve, NIPT is expanding into monogenic disorders: conditions caused by mutations in individual genes rather than whole chromosome abnormalities. At Eabha Genomics, we generate synthetic cfDNA for